Clinical trial
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
NCT03638206
Study timeline
Study start (actual)2018-03-01Date precision: day
Registry last updated2019-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
B-cell Acute Lymphoblastic Leukemiaunresolved
Lymphomaunresolved
Myeloid Leukemiaunresolved
Multiple Myelomaunresolved
Hepatomaunresolved
Gastric Cancerunresolved
Pancreatic Cancerunresolved
Mesotheliomaunresolved
Colorectal Cancerunresolved
Esophagus Cancerunresolved
Lung Cancerunresolved
Gliomaunresolved
Melanomaunresolved
Synovial Sarcomaunresolved
Ovarian Cancerunresolved
Renal Carcinomaunresolved
Interventions
CAR-T cell immunotherapyBIOLOGICAL
Sponsors & collaborators
Shenzhen BinDeBio Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03638206 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.